Sakura Finetek Europe Introduces Tissue-Tek SmartConnect
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

Sakura Finetek Europe Introduces Tissue-Tek SmartConnect

By Pharma Tech Outlook | Tuesday, November 03, 2020

Chris Koeman, President of Sakura Finetek Europe BV

Sakura Finetek Europe has launched its new advanced Tissue-Tek SmartConnect, an automated transfer system.

FREMONT, CA: Sakura Finetek Europe has launched its new advanced Tissue-Tek SmartConnect. It is an automated transfer system that develops a constant flow between the SMART solutions Tissue-Tek Xpress x120 Rapid Tissue Processor and Tissue-Tek AutoTEC a120 Automated Embedding System.

This latest advanced SMART solution helps a laboratory optimize their workflow to work more efficiently and even eliminate repetitive or unnecessary manual work. Therefore, laboratory technicians can prioritize what matters most, like taking care of the best possible patient journey.

Tissue-Tek SmartConnect is the first launch of Sakura Finetek Europe from its European research & development department. According to Andries Dragt, Vice President, Strategy & Business Development and founder of the idea, is very proud of Sakura Finetek’s European team, “Our team has done an outstanding job by creating this complex robotic solution in just two years with the extreme high-quality Sakura Finetek is known for. We created a fully automated process, starting with grossed tissues as input up to embedded blocks as output.” “With Tissue-Tek SmartConnect, Sakura Finetek once again proves itself as one of the most innovative companies when it comes to automating and standardising histology laboratories. This solution is a unique step towards future-proof pathology and enables lab technician to spend more of their valuable time on what really matters.”

In the next few months, the first histology laboratory will be prepared with Tissue-Tek SmartConnect to show its value and support the lab technicians in the workplace. Chris Koeman, President of Sakura Finetek, European, states, “This step is in line with our promise to empower pathology professionals to deliver accurate and fast diagnoses to optimize treatment success,” Chris Koeman.” “The patient drives this promise. Because when it comes to diagnosing cancer, there is no time to wait. We truly believe we can make more valuable differences for patients in the future, and that drives us to put all our effort into bringing more worthy innovations to the market.”

Sakura has a massive history of innovation and technology. The company introduced the first entirely enclosed tissue processor like Tissue-Tek VIP, rapid tissue processor, Tissue-Tek Xpress, the automated embedding system, and Tissue-Tek AutoTEC. The Tissue-Tek SmartConnect fits effortlessly in that line and brings numerous opportunities to future innovations.

Weekly Brief

Read Also